The Experimental Antipsychotic Agent 1192U90 Targets Tapetum Lucidum in Canine Eyes

Abstract

To assess the potential adverse effects in people of the antipsychotic agent 1192U90, we dosed mice, rats, beagles, and cynomolgus monkeys for up to 3 mo. In dogs, but not the other species, 1192U90 caused ocular changes detectable ophthalmoscopically as loss of tapetal reflectivity, altered tapetal color, and the appearance of black pigmentation on the tapetal fundus. Eyes from affected dogs had atrophic tapeta lucidum due to cell loss. Rodlets in remaining tapetal cells were separated by electron-lucent spaces or finely granular material, varied in size and shape, and often contained irregularly shaped electron-dense inclusions. Nontapetal ocular structures were unaffected. Because 1192U90 caused no ocular changes in nontapetal species, we hypothesized that it targeted only tapetum lucidum and spared other ocular structures. We tried to test this hypothesis by dosing congenitally atapetal dogs; however, although these dogs were ophthalmoscopically "atapetal," they had scattered tapetal cells visible by electron microscopy, and these tapetal cells had ultrastructural changes indistinguishable from those that occurred in treated normal-eyed dogs. Tapetal degeneration caused by 1192U90 resembled that described in hereditary tapetal degeneration in beagles. That 1192U90 caused no ocular changes in nontapetal species suggests that the ocular changes in dogs do not imply a risk for humans, whose eyes also lack a tapetum lucidum.

Keywords

Oculotoxicity atapetal dogs beagle

References

Buddinger JM (1961). Diphenylthiocarbazone blindness in dogs. Arch. Pathol. 71: 304-310.

Burns MS , Bellhorn RW , Impellizzeri W. , Aguirre GD , and Laties AM (1988). Development of hereditary tapetal degeneration in the beagle dog. Current Eye Res. 7: 103-114.

Cloyd GG , Wyman M. , Shadduck JA , Winrow MJ , and Johnson GR (1978). Ocular toxicity studies with zinc pyridinethione . Toxicol. Appl. Pharmacol. 45: 771-782.

Committee on Care and Use of Laboratory Animals ( 1985). Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23, U.S. Government Printing Office, Washington, D.C.

Delahunt CS , Stebbins RB , Anderson J. , and Bailey J. (1962). The cause of blindness in dogs given hydroxypyridinethione . Toxicol. Appl. Pharmacol. 4: 286-291.

Dykstra MJ (1993). A routine fixation and embedding schedule for transmission electron microscopy samples (tissues or cells). In: A Manual of Applied Techniques for Biological Electron Microscopy. Plenum Press, New York, pp. 12-16.

Dykstra MJ (1993). Staining ultrthin sections. In: A Manual of Applied Techniques for Biological Electron Microscopy. Plenum Press, New York, pp. 123-128.

Figueroa R. , Weiss H. , Smith JC Jr , Hackley BM , McBean LD , Swassing CR , and Halsted JA (1971). Effect of ethambutol on the ocular zinc concentration in dogs. Am. Rev. Resp. Dis. 104: 592-594.

Fortner JH , Milisen WB , Lundeen GR , Jakowski AB , and Marsh PM (1993). Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. Fund. Appl. Toxicol. 21: 164-173.

10.

Kaiser JA (1963). Tapetal depigmentation in dogs produced by ethylenediamines . Fed. Proc. 22: 369.

11.

Kaiser JA (1964). A one-year study of the toxicity of ethambutol in dogs: Results during life. Toxicol. Appl. Pharmacol. 6: 557-567.

12.

Massa T. , Davis GJ , Schiavo D. , Sinha DP , Szot RJ , Black HE , and Schwartz E. (1984). Tapetal changes in beagle dogs II. Ocular changes after intravenous administration of a macrolide antibiotic Rosaramicin. Toxiol. Appl. Pharmacol. 72: 195-200.

13.

Schiavo DM (1972). Retinopathy from administration of an imidazo quinazoline to beagles. Toxicol. Appl. Pharmacol. 23: 782-783.

14.

Schiavo DM , Green JD , Traina VM , Spaet R. , and Zaidi I. (1988). Tapetal changes in beagle dogs following oral administration of CGS 14796C, a potential aromatase inhibitor. Fund. Appl. Toxicol. 10: 329-334.

15.

Schiavo DM , Sinha DP , Black HE , Arthaud L. , Massa T. , Murphy BF , Szot FJ , and Schwartz E. (1984). Tapetal changes in beagle dogs I. Ocular changes after oral administration of a beta-adrenergic blocking agent SCH 19927. Toxicol. Appl. Pharmacol. 72: 187-194.

16.

Scholler J. , Brown DE , and Timmens EK (1961). Toxicological and pathological studies with diethyldithiocarbomate (DDC). Pharmacologist 3: 62.

17.

Snyder FH , Buehler EV , and Winek CL (1965). Safety evaluation of zinc 2-pyridinethiol 1-oxide in a shampoo formulation. Toxicol. Appl. Pharmacol. 7: 425-437.

18.

Vogel AW and Kaiser JA (1963). Ethambutol-induced transient change and reconstitution (in vivo) of the tapetum lucidum color in the dog. Exp. Mol. Pathol. Suppl. 2: 136-149.

19.

Weitzel G. , Strecker F-J. , Roester U. , Buddecke E. , and Fretzdorff A-M. (1954). Zink im tapetum lucidum. Hoppe-Seyler's Z. Physiol. Chem. 296: 19-30.